跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL
Authorized
STANDARD
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL
Bayer Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8431cb6464720da5
Company
Bayer Inc
Type
Standard
Approval Details
Approval Id
8431cb6464720da5
Drug Approval Canada Name
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL
Product Name
DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL
Status
Marketed
Status Date
2021-03-08
Original Market Date
2021-03-08
Din
02498308
Drug Class
Human
Dosage Form
Spray
Route Of Administration
Nasal
Schedule
OTC
Ahfs
52:32.00
Atc Original
R01AA05 OXYMETAZOLINE
Atc Name
r 01 aa 05
Aig Number
0101481001
Company Name
Bayer Inc
Company Address
2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6
Active Ingredients
OXYMETAZOLINE HYDROCHLORIDE
0.05 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8431cb6464720da5
Type
Standard
Back to Health Canada Approvals